Arabic Arabic English English French French German German
dark

Femasys Inc. Announces First Patient Treated in Pivotal Trial for FemaSeed

Femasys Inc. today announced the initiation and first patient treated in a pivotal trial evaluating FemaSeed, a first in class, localized directional insemination product candidate for infertility. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

The environmental toll of disposable masks

Next Post

XPhyto Signs Transformative Acquisition Agreement With 3a-Diagnostics, to Enter Hi-Tech Biosensor Market and Expand Its Diagnostic Product Portfolio

Related Posts
Total
0
Share